ProfileGDS5678 / 1439309_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 37% 38% 38% 38% 38% 39% 36% 38% 38% 43% 38% 38% 36% 38% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.8910437
GSM967853U87-EV human glioblastoma xenograft - Control 22.8687338
GSM967854U87-EV human glioblastoma xenograft - Control 32.873138
GSM967855U87-EV human glioblastoma xenograft - Control 42.818838
GSM967856U87-EV human glioblastoma xenograft - Control 52.8146938
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.9703939
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.8825736
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.8567538
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.8451138
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.9781843
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.8547838
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.8466838
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.8355736
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.8620638